FDA Inspection 1202371 - Seres Therapeutics Inc - December 14, 2022

Record Details

This FDA Inspection record concerns Seres Therapeutics Inc, with an inspection on December 14, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Seres Therapeutics Inc
Inspection Date: December 14, 2022
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · a3da2da2-4cfa-4f3b-a105-4b2fd9823473